论文部分内容阅读
中美上海施贵宝制药有限公司于6月20日在上海举办了血脂培训研讨会。上海各大医院的100多名心脑血管科医师出席了会议。上海瑞金医院心内科主任戚文航教授作了题为《中国心血管及其相关疾病的流行病学》和《脂质异常疾病治疗的临床研究》两个报告;上海中山医院韩琴琴教授讲授了《脂蛋白代谢基础》;上海中山医院心内科主任蔡乃绳教授宣讲了《脂质异常疾病治疗指南》。 上海施贵宝于去年7月发起的血脂培训是专为中
Sino-U.S. Shanghai Shiguibao Pharmaceutical Co., Ltd. held a lipid training seminar in Shanghai on June 20. More than 100 cardio-cerebral vascular surgeons from major hospitals in Shanghai attended the conference. Professor Qi Wenhang, director of the Department of Cardiology at Shanghai Ruijin Hospital, gave two reports entitled “Epidemiology of Cardiovascular Diseases and Related Diseases in China” and “Clinical Study on Treatment of Lipid Abnormal Diseases”; Professor Han Qinqin of Shanghai Zhongshan Hospital lectured on “Lipoproteins” Basic Metabolism; Professor Cai Naisheng, Director of Department of Cardiology, Shanghai Zhongshan Hospital, preached “Guidance on treatment of lipid abnormalities”. The blood lipid training initiated by Shanghai Shiguibao in July last year was specifically designed for